한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제38권1호
  • /
  • Pages.41-44
  • /
  • 2021
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지
DOI QR코드

DOI QR Code

Pituitary Pars Intermedia Dysfunction with Laminitis in a Horse

  • Lee, Eun-bee (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University) ;
  • Chun, Yong-woo (J&C Equine Hospital) ;
  • Park, Kyung-won (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University) ;
  • Kang, Tae-young (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University) ;
  • Seo, Jong-pil (College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University)
  • 투고 : 2020.05.20
  • 심사 : 2020.06.17
  • 발행 : 2021.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Pituitary pars intermedia dysfunction (PPID), often referred to as equine Cushing's disease, is a common endocrine disorder often diagnosed in older horses. A 13-year-old 460 kg Warmblood gelding showed clinical signs suggestive of PPID, including hypertrichosis, fat redistribution, polyuria and polydipsia (PU/PD), and weight loss. Physical examination, complete blood cell count, and serum chemistry results were normal. However, dexamethasone suppression and plasma adrenocorticotropic hormone (ACTH) level tests confirmed PPID. Three months after the confirmed diagnosis, the horse was referred again with symptoms of laminitis. Radiography and venography were performed to evaluate the laminitis severity level. However, the foot condition continued to worsen, and the horse was eventually euthanized. The purpose of this case report is to describe clinical signs and diagnosis of PPID with laminitis.

키워드

참고문헌

  1. Couetil L, Paradis MR, Knoll J. Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J Vet Intern Med 1996; 10: 1-6. https://doi.org/10.1111/j.1939-1676.1996.tb02016.x
  2. de Laat MA, McGowan CM, Sillence MN, Pollitt CC. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. Equine Vet J 2010; 42: 129-135.
  3. de Laat MA, Sillence MN, Reiche DB. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis. J Vet Intern Med 2019; 33: 1456-1463. https://doi.org/10.1111/jvim.15419
  4. Donaldson MT, McDonnell SM, Schanbacher BJ, Lamb SV, McFarlane D, Beech J. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J Vet Intern Med 2005; 19: 217-222. https://doi.org/10.1892/0891-6640(2005)19<217:VIPAHC>2.0.CO;2
  5. Dybdal NO, Hargreaves KM, Madigan JE, Gribble DH, Kennedy PC, Stabenfeldt GH. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 1994; 204: 627-632.
  6. Frank N, Andrews FM, Sommardahl CS, Eiler H, Rohrbach BW, Donnell RL. Evaluation of the combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses. J Vet Intern Med 2006; 20: 987-993. https://doi.org/10.1892/0891-6640(2006)20[987:EOTCDT]2.0.CO;2
  7. Garcia MC, Beech J. Equine intravenous glucose tolerance test: Glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J V et Res 1986; 47: 570-572.
  8. Grenager N. How does Cushing's disease relate to laminitis? Advances in diagnosis and treatment. J Equine Vet Sci 2010; 30: 482-490. https://doi.org/10.1016/j.jevs.2010.07.015
  9. Johnson PJ, Kreeger JM, Keeler M, Ganjam VK, Messer NT. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. Equine Vet J 2000; 32: 462-468. https://doi.org/10.2746/042516400777584695
  10. Karikoski NP, Patterson-Kane JC, Singer ER, McFarlane D, McGowan CM. Lamellar pathology in horses with pituitary pars intermedia dysfunction. Equine Vet J 2016; 48: 472-478. https://doi.org/10.1111/evj.12450
  11. Love S. Equine Cushing's disease. Br Vet J 1993; 149: 139-153. https://doi.org/10.1016/s0007-1935(05)80084-3
  12. McGowan TW, Pinchbeck GP, McGowan CM. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses. Equine Vet J 2012; 45: 74-79. https://doi.org/10.1111/j.2042-3306.2012.00578.x
  13. McFarlane D, Miller LM, Craig LE, Dybdal NO, Habecker PL, Miller MA, Patterson JS, Cribb AE. Agreement in histologic assessments of the pituitary pars intermedia in aged horses. Am J Vet Res 2005; 66: 2055-2059. https://doi.org/10.2460/ajvr.2005.66.2055
  14. McFarlane D. Equine pituitary pars intermedia dysfunction. Vet Clin N Am Equine Pract 2011; 27: 93-113. https://doi.org/10.1016/j.cveq.2010.12.007
  15. Patterson-Kane JC, Karikoski NP, McGowan CM. Paradigm shifts in understanding equine laminitis. Vet J 2018; 231: 33-40. https://doi.org/10.1016/j.tvjl.2017.11.011
  16. Rohrbach BW, Stafford JR, Clermont RSW, Reed SM, Schott HC 2nd, Andrews FM. Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary pars intermedia dysfunction, 1993-2004. J Vet Intern Med 2012; 26: 1027-1034. https://doi.org/10.1111/j.1939-1676.2012.00932.x
  17. Schott HC 2nd. Pituitary pars intermedia dysfunction: Equine Cushing's disease. Vet Clin North Am Equine Pract 2002; 18: 237-270. https://doi.org/10.1016/S0749-0739(02)00018-4
  18. Spelta C. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management. Int J Vet Med 2015; 6: 293-300.